TNBC/TLS− and HER2+/TLS− (HER2 and Luminal B_HER2) subgroups are identified to be highly aggressive subgroups where a high recurrence rate seems to emerge from a crosstalk between tumor and stromal components. The gene discussed is ERBB2; the disease is neoplasm.